Literature DB >> 18339309

The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice.

Misak Yazdi1, Andrea Ahnmark, Lena William-Olsson, Michael Snaith, Nigel Turner, Fredrik Osla, Marianne Wedin, Anna-Karin Asztély, Anders Elmgren, Mohammad Bohlooly-Y, Sandra Schreyer, Daniel Lindén.   

Abstract

Glycerol-3-phosphate acyltransferase (GPAT) is involved in triacylglycerol (TAG) and phospholipid synthesis, catalyzing the first committed step. In order to further investigate the in vivo importance of the dominating mitochondrial variant, GPAT1, a novel GPAT1(-/-) mouse model was generated and studied. Female GPAT1(-/-) mice had reduced body weight-gain and adiposity when fed chow diet compared with littermate wild-type controls. Furthermore, GPAT1(-/-) females on chow diet showed decreased liver TAG content, plasma cholesterol and TAG levels and increased ex vivo liver fatty acid oxidation and plasma ketone bodies. However, these beneficial effects were abolished and the glucose tolerance tended to be impaired when GPAT1(-/-) females were fed a long-term high-fat diet (HFD). GPAT1-deficiency was not associated with altered whole body energy expenditure or respiratory exchange ratio. In addition, there were no changes in male GPAT1(-/-) mice fed either diet except for increased plasma ketone bodies on chow diet, indicating a gender-specific phenotype. Thus, GPAT1-deficiency does not protect against HFD-induced obesity, hepatic steatosis or whole body glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339309     DOI: 10.1016/j.bbrc.2008.02.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity.

Authors:  Francis P Kuhajda; Susan Aja; Yajun Tu; Wan Fang Han; Susan M Medghalchi; Rajaa El Meskini; Leslie E Landree; Jonathan M Peterson; Khadija Daniels; Kody Wong; Edward A Wydysh; Craig A Townsend; Gabriele V Ronnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-13       Impact factor: 3.619

Review 2.  Hepatic triacylglycerol accumulation and insulin resistance.

Authors:  Cynthia A Nagle; Eric L Klett; Rosalind A Coleman
Journal:  J Lipid Res       Date:  2008-11-06       Impact factor: 5.922

Review 3.  Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

Authors:  Rosalind A Coleman; Douglas G Mashek
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

4.  Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity.

Authors:  Angela A Wendel; Lei O Li; Yue Li; Gary W Cline; Gerald I Shulman; Rosalind A Coleman
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

Review 5.  How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage.

Authors:  Huan Wang; Michael V Airola; Karen Reue
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-20       Impact factor: 4.698

Review 6.  Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms.

Authors:  Jose Antonio Chavez; Scott A Summers
Journal:  Biochim Biophys Acta       Date:  2009-09-29

Review 7.  Hepatic fatty acid trafficking: multiple forks in the road.

Authors:  Douglas G Mashek
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

8.  Mitochondria-type GPAT is required for mitochondrial fusion.

Authors:  Yohsuke Ohba; Takeshi Sakuragi; Eriko Kage-Nakadai; Naoko H Tomioka; Nozomu Kono; Rieko Imae; Asuka Inoue; Junken Aoki; Naotada Ishihara; Takao Inoue; Shohei Mitani; Hiroyuki Arai
Journal:  EMBO J       Date:  2013-04-09       Impact factor: 11.598

9.  The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding.

Authors:  Bradley S Henriksen; Mary E Curtis; Natasha Fillmore; Brandon R Cardon; David M Thomson; Chad R Hancock
Journal:  Diabetol Metab Syndr       Date:  2013-05-31       Impact factor: 3.320

Review 10.  Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.

Authors:  Barbara Fruci; Stefania Giuliano; Angela Mazza; Roberta Malaguarnera; Antonino Belfiore
Journal:  Int J Mol Sci       Date:  2013-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.